NeurAxis, Inc. NRXS
At closeNov 4, 2026, 4:00 PM EST
After hours · Nov 4, 4:00 PM ET
Day range unavailable
- YTD
- +51.10%
- 1 year
- +170.08%
- Market cap
- 86.15M
- Revenue (ttm)
- 2.27M
- EPS (ttm)
- -0.78
- Shares out
- 6.98M
- Forward P/E
- -23.30
- YTD return
- +51.10%
- 1-year return
- +170.08%
- Avg volume
- 130.18K
- Previous close
- 6.86
- 52-week range
- 2.21 – 9.33
6M -1.72 (-20.72%)
Key statistics
- Enterprise value
- 24.97M
- PEG ratio
- 0.00
- Price / sales
- 7.17
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -5.30%
- Free cash flow
- -10.40M
- Total cash
- 1.77M
- Total debt
- 5.11M
- Return on equity
- 0.00%
- Short % of float
- 0.18%
- 50-day average
- 2.83
- 200-day average
- 3.01
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | -0.25 | — | — |
| Aug 9, 2024 | Jun 1, 2024 | 0.00 | -0.42 | — | — |
| May 20, 2024 | Mar 1, 2024 | 0.00 | -0.32 | — | — |
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | -1.06 | — | — |
About NeurAxis, Inc.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- neuraxis.com
News
NeurAxis Announces Its Medical Policy Coverage Now Serves Over 26M Medical Plan Members 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M Estimate 
12 Health Care Stocks Moving In Monday's Pre-Market Session 
Neuraxis Reports Q1 2026 Results: Full Earnings Call Transcript 
Earnings Scheduled For May 12, 2026 
Neuraxis Q1 EPS $(0.18) Beats $(0.19) Estimate, Sales $1.607M Beat $1.450M Estimate 
Craig-Hallum Maintains Buy on Neuraxis, Raises Price Target to $13 - Earnings Scheduled For March 19, 2026
- Neuraxis Q4 EPS $(0.17) Beats $(0.21) Estimate, Sales $968.127K Beat $850.000K Estimate
Your note
Sign in to keep a note on NRXS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FERGE KRISTIN A | Director | Stock Award(Grant) | Jun 27, 2024 | 1,183 |
| HANNASCH BRIAN | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Feb 19, 2024 | 757,901 |
| KEYSER JANE ELIZABETH | Director | Stock Award(Grant) | Jun 27, 2024 | 11,580 |
| MASIMO CORP. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 10, 2023 | 531,548 |
| WATKINS BRADLEY MITCHELL | Director | Stock Award(Grant) | Jun 27, 2024 | 11,580 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bank of Montreal /CAN/ | 2.13% | 149,017 | 347.21K | Sep 29, 2024 |
| Vanguard Group Inc | 0.40% | 27,981 | 65.19K | Sep 29, 2024 |
| Stifel Financial Corporation | 0.37% | 25,710 | 59.90K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.33% | 22,704 | 52.90K | Sep 29, 2024 |
| Royal Bank of Canada | 0.22% | 15,101 | 35.19K | Sep 29, 2024 |
| Parsons Capital Management, Inc. | 0.19% | 13,000 | 30.29K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.25% | 17,745 | 41.34K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.25% | 17,755 | 41.37K | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 0.15% | 10,236 | 23.85K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 4,261 | 9.93K | Oct 30, 2024 |